Docking prediction analysis is a computerized model which can aid in developing new potential bacterial targets for antibiotics. Trying to find a molecule with a high potential binding with its macromolecule (protein) is challenging. The bacterial cross talk (quorum sensing [QS]) mechanisms are bacterial regulation processes which allow bacteria to express pathogenic phenotypes such as biofilm formation. By targeting the QS components, a novel way of affecting bacterial behavior is achieved, possibly without creating antibiotic resistance. We conducted a combined analysis of a new synthetic drug with a docking in silico prediction applied on potential QS targets in Pseudomonas aeruginosa, and by doing so validated previous docking results of other QS inhibitors. We complemented the in silico analysis with an in vitro E. coli -QS reporting assay in order to confirm a new class of QS inhibitors. Our analysis was confirmed after conducting site-directed mutagenesis over the sequences of the potential binding amino acid residues of the suspected QS inhibitor target. Our analysis was supported by a wide meta-genomic microarray analysis which revalidated the QS inhibition schema. The QS inhibitor successfully exhibited a decrease in the pathogenic phenotypes of surface attached biofilm and swarming motility in P. aeruginosa.
Quorum sensing [QS] is a mechanism of communication which is utilized by many species of bacteria. QS is used as a means to coordinate a bacterial population's response to outside stressors, such as nutrient deprivation and oxidative stress [1, 2] . QS contributes to bacterial pathogenicity; the bacteria's behavior is coordinated at the community level against host immune responses, which protects and sustains the population as a whole [1, 3] . QS has been found to influence many aspects of bacterial behavior, including motility, searching for carbon source, and biofilm formation [4] . Quorum sensing is an important mechanism in the production of a biofilm, and P. aeruginosa has emerged as a model organism for research in these fields [2] . One type of quorum-sensing molecule utilized by P. aeruginosa is the N-Acyl-Homoserine Lactone (AHL) group. The bacterial cell membrane is permeable to this molecule, so its intracellular
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and extracellular concentrations are equal. When the population density rises, so does the amount of AHL excreted into the environment, thus raising its extracellular concentration, which in turn causes the intracellular concentration to rise [5] . When the concentration rises beyond a certain threshold, the autoinducer molecule binds to an intracellular receptor. This autoinducer-receptor complex is a transcription factor for myriad genes [6, 7] . Researchers have discovered two lux-type gene groups involved in quorum sensing in P. aeruginosa: rhl and las. The gene products of lasI and rhlI are enzymes that catalyze the production of the autoinducer molecules (3-oxo-C12-HSL and C4-HSL, respectively). The gene products of lasR and rhlR are the receptors for the autoinducers [8, 9] . The las gene group is at the top of the QS hierarchy in P. aeruginosa.
Recent studies have searched for a specific targeting molecule inhibitor to the las system, but most studies found multiple targeting to be the result [10, 11] . The structure of LasI is homologous to other luxI-type proteins such as TofI in Burkholderia glumae and EsaI in Pantoea stewartii; it contains a small hydrophobic pocket for acyl-chain binding [e.g V-cleft] which is responsible for building the strain specific HSL molecule in the LuxI-type protein [12] .
The main goal of our research was to find an inhibitor of biofilm formation in P. aeruginosa. Researchers have found that virulence in this bacterium, especially lethality in patients suffering from cystic fibrosis, is related to its capability of forming biofilm [13] . Thus we decided to study biofilm inhibition rather than QS inhibition, since this inhibition would be meaningless unless a clear antibiotic affect was found.
Specificity is important in the search for a new QS inhibitor. As is the case of other QS inhibitors [14, 15] , the drug should affect its target at the lowest possible concentration, under the range of the minimal inhibitory concentration (MIC). The drug should interact primarily with its target, in this case the protein which is responsible for initiating the QS response which is correlated with the biofilm formation phenotype (or any other pathogenic trait).
Many studies have been conducted in the field of QS inhibition; one approach is to synthesize molecules analogous to endogenous ligands as potential inhibitors of the QS receptor proteins in the P. aeruginosa QS families; LasR, RhlR, and PqsR (mvfR) [10, 11, 16] . Other researchers study compounds found in nature for their QS inhibition capabilities. Examples include trans-cinnamaldehyde and flavonoids, derived from the sea alge Delisea pulchara and the Psidium guajava L. plant, respectively [11, 15] . We hoped to explore TZD derivatives; a new class of synthetic molecules which have shown an inhibitory effect on QS in Vibrio Harveyi (inhibition of LuxS) [14] . Additionally, they have shown an inhibitory effect in Candida spp. [17] . TZD derivatives have been extensively studied and reported on in the medical literature. They are classified as peroxisome proliferator-activated receptor (PPAR) agonists, a class of oral hypoglycemic agents used in Type II Diabetes Mellitus. Thus, their toxicity profile allows for use in humans, an important consideration in regards to developing a future drug for QS inhibition.
Recently we utilized a new mechanistic approach ( Figure  1 ) combining in silico prediction of molecule docking and in vitro complementation in order to validate QS inhibition specificity [18] . In this approach we mutagenized the sequence of the predicted QS inhibitor's target, LasI, in specific amino acid residues, while conducting an in vitro exploration of the QS pathway, from the master regulator las onto the pqs and rhl systems. A modified E. coli-based high throughput bioassay enabled us to detect the smallest change in las HSL production. We used agar plated with the E. coli bioreporter harboring the LasR reporter. A 5 µl aliquot of the bacterial extract was absorbed onto a 7 mm paper disk, which was then placed on the agar plate.
The amount of HSL produced was reported as a blue zone created on the agar, which was then solubilized by melting the agar to an even suspension. The absorbance of the agar suspension was measured in a spectrophotometer at a wavelength of 650 nm [18, β-Gal modified assay, Supplemented information].
The function of the QS systems downstream to las were also studied with the mutagenized LasI. The rhl system was monitored similarly to the las system with the modified E. coli bio-reporting assay. Pqs activity was detected via a TLC analysis; this analysis also indicated QS inhibition, which correlated with the las inhibition.
The study was further supported by a metagenomic microarray analysis. Microarray analysis is capable of showing the effect on transcription exerted by the inhibitor, and the results confirmed the complete inhibition of the entire pqs operon. Additionally, the microarray data supported other phenotypes extended from the transcription pattern, such as the biofilm formation inhibition aided by the QS controlled genes. The swarming phenotype, which usually correlates with an effect on the rhl system, was instead found to directly correlate with an effect on the las system [18, Figure S4 ].
The in silico docking prediction results in our study were similar to other studies of QS inhibitors involving docking analysis, such as the study of trans-cinnamaldehyde, which was predicted to bind LasI similarly to our tested TZD-C8 molecule [11] . Such docking similarity also exists with TofI, a LasI homolog, whose interaction schema bear a close resemblance to those of LasI [18, Figure S7 ]. We further analyzed the amino acid residues involved in direct interaction with our synthetic molecule by site-directed mutagenesis of the predicted amino acid residues at the docking site for TZD-C8. Although some minor LasI functionality was partially impaired, the overall settings allowed us to visualize the abolishment of the QS inhibition caused by the synthetic TZD-C8 inhibitor after being in contact with the mutagenized LasI protein.
In conclusion, this novel approach of in silico to in vitro analysis may aide the search for new antibiotics. There is a growing need for a computational tool to facilitate the screening for biologically active compounds. In our study, we showed evidence of an in silico tool which may help to do so. This approach is validated by metagenomic analysis but will be still need to go through a direct binding assay in order to confirm our findings. We measured the effect of a synthetic QS inhibitor in P. aeruginosa while observing its impact on bacterial pathogenicity as expressed by a decrease in biofilm formation and swarming motility. The positive effect we observed supports our exploration approach, which can be implemented to identify inhibitors of other pathogenic proteins and hopefully develop novel antibiotics.
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